Fluvastatin Capsule
Product Images NDC 71335-2933

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin (NDC 71335-2933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Fluvastatin (Image 1)

Chemical structure diagram of the active ingredient Fluvastatin, showing its molecular configuration including aromatic rings, hydroxyl groups, and a sodium ion (Na+).*

FDA Label Image

1 (Image 2)

A Kaplan-Meier survival curve showing the percentage of patients without events over time for Fluvastatin 80 mg compared to placebo. The graph includes statistical data such as Cox and Log-Rank P-values and a hazard ratio with confidence intervals. Patient numbers at risk and survival counts are detailed below the x-axis.*

FDA Label Image

1 (Image 3)

A forest plot chart illustrating risk reduction percentages and 95% confidence intervals for various cardiac events comparing Fluvastatin versus placebo. Events include primary and secondary cardiac outcomes, such as recurrent cardiac events, cardiac death, myocardial infarction, and revascularization. The chart visually presents hazard ratios favoring either Fluvastatin or placebo with corresponding confidence intervals.*

FDA Label Image

1 (Image 4)

A bar chart showing change in minimum lumen diameter (mm) across three patient groups: Monotherapy, All Patients, and Combination Therapy. The chart compares Fluvastatin and placebo treatments, with numerical change values and p-values indicated below each bar. Combination therapy includes cholestyramine (CME).*

FDA Label Image

1 (Image 5)

A bar chart depicting the change in percentage diameter stenosis for Fluvastatin versus placebo. It includes three groups: Monotherapy, All Patients, and Combination Therapy with cholestyramine (CME). Values and p-values indicate statistical comparisons between Fluvastatin and placebo groups for each category.*

FDA Label Image

Label (Lbl713352933)

This label is for Fluvastatin Capsules, USP, with a strength of 40 mg. The package contains 100 capsules intended for oral use, labeled as prescription only. It is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Teva Pharmaceutical Ind. Ltd. Storage instructions recommend protecting from light and keeping at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.